公开(公告)号：US20180104303A1

公开(公告)日：2018-04-19

申请号：US15119032

申请日：2015-02-18

Applicant: UNIVERSITE DE LA ROCHELLE ,  UNIVERSITÉ BLAISE PASCAL-CLERMONT II

Inventor： Thierry MAUGARD ,  Stephanie BORDENAVE-JUCHEREAU ,  Jean-Marie PIOT ,  Yesmine BEN-HENDA ,  Pascal SIRVENT ,  Sebastien PELTIER

IPC: A61K38/06 ,  A61P3/10 ,  A61K38/00 ,  A61K38/01 ,  A23L33/18 ,  A23L33/00 ,  A61K45/06

CPC classification number: A61K38/06 ,  A23L33/18 ,  A23L33/30 ,  A23V2002/00 ,  A61K38/005 ,  A61K38/01 ,  A61K38/05 ,  A61K45/06 ,  A61P3/10

Abstract: A composition including at least one XAP peptide, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase. Also, the use of a hydrolysate of at least one protein, the protein including or constituted by at least 0.05% to

公开(公告)号：US20200009101A1

公开(公告)日：2020-01-09

申请号：US16486381

申请日：2018-02-13

Applicant: VALBIOTIS ,  UNIVERSITE CLERMONT AUVERGNE ,  UNIVERSITE DE LA ROCHELLE ,  CNRS

Inventor： Sebastien PELTIER ,  Vivien CHAVANELLE ,  Florian LE JOUBIOUX ,  Pascal SIRVENT ,  Thierry MAUGARD

IPC: A61K31/216 ,  A61K31/7048 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10

Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-2H -pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.